Cefuroxime-Darnitsa powder for solution for injection 1.5 g bottle No. 1




Cefuroxime-Darnitsa powder for injection is indicated for the treatment of infections caused by microorganisms sensitive to cefuroxime, or the treatment of infections until the causative agent of the infectious disease is identified.
Composition
Active ingredient: cefuroxime;
1 vial contains sterile cefuroxime sodium equivalent to 1.5 g of anhydrous cefuroxime;
Contraindication
Hypersensitivity to cefuroxime. Hypersensitivity to cephalosporin antibiotics. History of severe hypersensitivity (e.g. anaphylactic reactions) to other beta-lactam antibiotics (penicillins, monobactams and carbapenems).Method of application
Susceptibility to the drug varies between regions and may change over time. Local antibiotic susceptibility data should be consulted if necessary.
Injections are intended for intravenous or intramuscular administration only.
No more than 1.5 g of the drug should be administered intramuscularly in one injection at one site.
For administration, add 3 ml of water for injection to 1.5 g of the drug. Shake gently until an opaque suspension is formed.
For administration, dissolve 1.5 g of the drug in not less than 15 ml of water for injections. For infusions lasting no more than 30 minutes, 1.5 g of cefuroxime can be dissolved in 50-100 ml of water for injections. The resulting solutions can be administered directly into a vein or into a drip tube for infusion therapy.
During storage of already diluted solutions, changes in color saturation may occur.
Application features
Pregnant women
It should be prescribed with caution in the first months of pregnancy.
Children
Apply to children from the first days of life.
Drivers
No data.
Overdose
Overdose of cephalosporin antibiotics may lead to symptoms of brain irritation, which may result in convulsions. Cefuroxime levels can be reduced by hemodialysis or peritoneal dialysis.
Side effects
From the blood and lymphatic system:
often - neutropenia, eosinophilia.From the hepatobiliary system:
often - transient increase in liver enzymes.General disorders and administration site conditions
Common: Injection site reactions, which may include pain and thrombophlebitis.Interaction
Like other antibiotics, the drug may affect the intestinal flora, leading to reduced reabsorption of estrogens and reduced effectiveness of combined oral contraceptives.
Storage conditions
Store at a temperature not exceeding 25 °C.
Keep out of reach of children.
Shelf life - 3 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.